Head-to-head · WeighScore
Invigor Medical vs Refills
By GLP-1 ScorecardUpdated
Score comparison
Invigor Medical has the higher recorded score — 86.1/100 to 51/100.
Invigor Medical grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. An established pharmacy operator with steady mid-market pricing and a broad catalog.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Invigor Medical | Refills |
|---|---|---|
| WeighScore | 86.1/100 | 51/100 |
| Grade | B | C |
| Site position | #10 | #530 |
| Semaglutide | $199/mo | Not disclosed |
| Tirzepatide | $339/mo | Not disclosed |
| Coverage | Not disclosed | Coverage not published |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Site position #10 · B
Strengths
- Mid-market pricing on both molecules
- Long-running operator
What to consider
- No explicit states list
- Compounded only
Site position #530 · C
FDAWarning letter issued to Refills Health, LLC dba Refills Health in February 2026. See the FDA warning-letter database.
Strengths
- LegitScript Certified online pharmacy
- Claims operation across all 50 states (with some exclusions)
- Multi-category platform (weight loss + ED + hair growth + wellness) — single account for multiple treatments
- Free shipping disclosed publicly
- Cash-pay, no insurance needed
What to consider
- Ongoing monthly pricing for compounded semaglutide and tirzepatide not shown until after intake
- Legal entity name and state of incorporation not disclosed
- Compounding pharmacy partner not named
- Excluded states not listed in marketing copy — verify coverage during intake
- FDA issued Refills Health, LLC dba Refills Health a warning letter in February 2026; the letter is public in FDA's warning-letter database
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.